Pages that link to "Q33802543"

The following pages link to ATP site-directed competitive and irreversible inhibitors of protein kinases (Q33802543):

Displaying 37 items.

• Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity (Q27320733) (← links)
• Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine (Q27628650) (← links)
• Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole (Q27635437) (← links)
• Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor (Q27639528) (← links)
• Crystal structure of aurora-2, an oncogenic serine/threonine kinase (Q27639665) (← links)
• Inhibition of protein kinase CK2 by anthraquinone-related compounds. A structural insight (Q27639922) (← links)
• The structure of JNK3 in complex with small molecule inhibitors: structural basis for potency and selectivity (Q27641951) (← links)
• Aminoglycoside 2′′-Phosphotransferase IIIa (APH(2′′)-IIIa) Prefers GTP over ATP (Q27677499) (← links)
• Chemogenomic approaches to drug discovery (Q28208482) (← links)
• PfPKB, a novel protein kinase B-like enzyme from Plasmodium falciparum: I. Identification, characterization, and possible role in parasite development (Q30041460) (← links)
• Trends in Kinase Selectivity: Insights for Target Class-Focused Library Screening (Q33762539) (← links)
• Toxoplasma gondii cyclic GMP-dependent kinase: chemotherapeutic targeting of an essential parasite protein kinase (Q33904366) (← links)
• Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape (Q33920097) (← links)
• Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase (Q33943764) (← links)
• Chemical proteomics and its application to drug discovery (Q35059112) (← links)
• Tyrosine kinases as targets in cancer therapy - successes and failures (Q35095147) (← links)
• Therapeutic potential of phosphoinositide 3-kinase inhibitors. (Q35096803) (← links)
• In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases (Q35125012) (← links)
• Directed discovery of agents targeting the Met tyrosine kinase domain by virtual screening (Q37231567) (← links)
• Marine pyrrolocarbazoles and analogues: synthesis and kinase inhibition (Q37680686) (← links)
• Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview (Q38989374) (← links)
• Organometallic compounds with biological activity: a very selective and highly potent cellular inhibitor for glycogen synthase kinase 3. (Q40252764) (← links)
• Structure-aided optimization of kinase inhibitors derived from alsterpaullone. (Q40461072) (← links)
• Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors (Q40509516) (← links)
• Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2'). (Q43601491) (← links)
• Convergent synthesis of potent peptide inhibitors of the Grb2-SH2 domain by palladium catalyzed coupling of a terminal alkyne (Q43608747) (← links)
• Structural basis for the activity of pp60(c-src) protein tyrosine kinase inhibitors (Q43629456) (← links)
• Similarity searching in large combinatorial chemistry spaces (Q43701172) (← links)
• Intracellular Targets of Paullones. Identification following affinity purification on immobilized inhibitor (Q43966314) (← links)
• In vitro biotransformation of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine by mouse liver microsomes (Q44252914) (← links)
• Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3. (Q44563618) (← links)
• Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases (Q44754701) (← links)
• A liquid chromatography/mass spectrometry-based method for the selection of ATP competitive kinase inhibitors (Q46644558) (← links)
• Kinase-targeted cancer therapies: progress, challenges and future directions (Q49887882) (← links)
• Classification of kinase inhibitors using BCUT descriptors (Q73323042) (← links)
• Understanding kinase selectivity through energetic analysis of binding site waters (Q83030277) (← links)
• Pd/PTABS: An Efficient Water-Soluble Catalytic System for the Amination of 6-Chloropurine Ribonucleoside and Synthesis of Alogliptin (Q91060275) (← links)